Synthesis of novel steroidal agonists, partial agonists, and antagonists for the glucocorticoid receptor

https://doi.org/10.1016/j.bmcl.2016.11.007Get rights and content

Abstract

Adverse effects of glucocorticoids could be limited by developing new compounds that selectively modulate anti-inflammatory activity of the glucocorticoid receptor (GR). We have synthesized a novel series of steroidal GR ligands, including potent agonists, partial agonists and antagonists with a wide range of effects on inhibiting secretion of interleukin-6. Some of these new ligands were designed to directly impact conformational stability of helix-12, in the GR ligand-binding domain (LBD). These compounds modulated GR activity and glucocorticoid-induced gene expression in a manner that was inversely correlated to the degree of inflammatory response. In contrast, compounds designed to directly modulate LBD epitopes outside helix-12, led to dissociated levels of GR-mediated gene expression and inflammatory response. Therefore, these new series of compounds and their derivatives will be useful to dissect the ligand-dependent features of GR signaling specificity.

Graphical abstract

Adverse effects of glucocorticoids could be limited by developing new compounds that selectively modulate anti-inflammatory activity of the glucocorticoid receptor (GR). We have synthesized a novel series of steroidal GR ligands, including potent agonists, partial agonists and antagonists with a wide range of effects on inhibiting secretion of interleukin-6. Some of these new ligands were designed to directly impact conformational stability of helix-12, in the GR ligand-binding domain (LBD). These compounds modulated GR activity and glucocorticoid-induced gene expression in a manner that was inversely correlated to the degree of inflammatory response. In contrast, compounds designed to directly modulate LBD epitopes outside helix-12, led to dissociated levels of GR-mediated gene expression and inflammatory response. Therefore, these new series of compounds and their derivatives will be useful to dissect the ligand-dependent features of GR signaling specificity.

  1. Download : Download high-res image (64KB)
  2. Download : Download full-size image

Section snippets

Acknowledgments

Authors are grateful for Dr. Glenn C. Micalizio, The Scripps Research Institute, FL and Dartmouth College for donating intermediate 2.

References (40)

  • E.M. Cohen

    Anal Profiles Drug Subst

    (1973)
  • J.D. Slater et al.

    Lancet

    (1959)
  • A. Pecci et al.

    J Steroid Biochem Mol Biol

    (2009)
  • J.L. Gilmore et al.

    Bioorg Med Chem Lett

    (2013)
  • C.J. Smith et al.

    Bioorg Med Chem Lett

    (2005)
  • V.K. Arora et al.

    Cell

    (2013)
  • Y. Chinenov et al.

    Mol Cell Endocrinol

    (2013)
  • D.M. Lonard et al.

    Mol Cell

    (2007)
  • B. Kauppi et al.

    J Biol Chem

    (2003)
  • K.P. Madauss et al.

    Bioorg Med Chem Lett

    (2008)
  • E. Stephan et al.

    Steroids

    (1995)
  • J.B. Grimm et al.

    Tetrahedron Lett

    (2007)
  • T. Perlmann et al.

    J Biol Chem

    (1990)
  • E. Wright et al.

    Structure

    (2011)
  • R. Hirschmann et al.

    J Am Chem Soc

    (1963)
  • J.H. Fried et al.

    J Am Chem Soc

    (1963)
  • R.D. Clark

    Curr Top Med Chem

    (2008)
  • L. Matthews et al.

    Endocrinology

    (2009)
  • A. Ali et al.

    J Med Chem

    (2004)
  • R.P. Robinson et al.

    J Med Chem

    (2009)
  • Cited by (0)

    View full text